We provide you with 20 years of free, institutional-grade data for HAPP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HAPP. Explore the full financial landscape of HAPP stock.
| Reported Date | CIK | Ticker | Type |
|---|
Happiness Biotech Group Limited(NASDAQ:HAPP) 
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, America...
Website: http://www.happ.org.cn
IPO Price: $5.5 (Oct 25, 2019)
Full Time Employees: 151 (May 2021)
CEO: Wang Xuezhu
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends
The information provided in this report about HAPP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.